An Evaluation of the Efficacy and Safety of TOLAMBA™ for Ragweed-Allergic Rhinitis in an Environmental Exposure Chamber

NCT00537355 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

271

Enrollment

INDUSTRY

Sponsor class

Conditions

Rhinitis, Allergic, Seasonal

Interventions

BIOLOGICAL: Amb a 1 Immunostimulatory Oligoribonucleotide Conjugate
DRUG: Histamine

Sponsor

Dynavax Technologies Corporation